A Phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure

Emerson C. Perin, Kenneth M. Borow, Guilherme V. Silva, Anthony N. DeMaria, Oscar C. Marroquin, Paul P. Huang, Jay H. Traverse, Henry Krum, Donna Skerrett, Yi Zheng, James T. Willerson, Silviu Itescu, Timothy D. Henry

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Fingerprint Dive into the research topics of 'A Phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences